Published in Gene Therapy Weekly, October 27th, 1997
If further testing proves that the method can identify women in whom breast cancer most likely will recur, it could help cancer treatment specialists decide whether or not to institute aggressive anti-cancer therapy on affected patients.
The screening method uses a polymerase chain reaction (PCR) probe that signals the presence or absence of up to four genes that have been associated with breast cancer. When the PCR probe finds any one of the genes in DNA from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.